Changes of Cerebral Biopterin and Biogenic Amine Metabolism in Leukemic Children Receiving 5 g/m2 Intravenous Methotrexate View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1995-02

AUTHORS

F Millot, J L Dhondt, F Mazingue, F Mechinaud, P Ingrand, F Guilhot

ABSTRACT

Acute or subacute neurologic disorders can be observed in patients receiving high-dose methotrexate therapy for lymphoblastic leukemia or malignant tumor. Impairment of biopterin metabolism leading to decreased availability of monoamine neurotransmitters has been suggested to explain methotrexate neurotoxicity. To investigate such a mechanism, we have measured prospectively by HPLC the concentrations of total biopterin, homovanillic acid, and 5-hydroxyindolacetic acid in cerebrospinal fluid of 57 children with acute lymphoblastic leukemia. A sequential analysis of cerebrospinal fluid was performed for each patient: cerebrospinal fluid samples were obtained before therapy and after each of the four high-dose methotrexate infusions during the CNS prophylaxis phase. A significant increase of total biopterin concentrations in cerebrospinal fluid was observed after high-dose methotrexate therapy compared with the pretreatment values. No cumulative effect was noted. In contrast, no significant variation of the homovanillic acid and 5-hydroxyindolacetic acid levels was observed in cerebrospinal fluid. However, individual analysis revealed a transient decrease of homovanillic acid and 5-hydroxyindolacetic acid concentrations in cerebrospinal fluid of six children. The increase of total biopterin mimicking that observed in inherited dihydropteridine reductase deficiencies suggests that methotrexate inhibits the regenerating system of biopterin in the brain of patients undergoing high-dose methotrexate therapy. More... »

PAGES

151

References to SciGraph publications

  • 1985-03. Clinical role of pteridine therapy in tetrahydrobiopterin deficiency in JOURNAL OF INHERITED METABOLIC DISEASE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1203/00006450-199502000-00004

    DOI

    http://dx.doi.org/10.1203/00006450-199502000-00004

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1001684512

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/7537364


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adolescent", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Combined Chemotherapy Protocols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biogenic Amines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biopterin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Brain Chemistry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child, Preschool", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chromatography, High Pressure Liquid", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cytarabine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dihydropteridine Reductase", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Homovanillic Acid", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hydroxyindoleacetic Acid", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Infant", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Infusions, Intravenous", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mercaptopurine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Methotrexate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nerve Tissue Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Precursor Cell Lymphoblastic Leukemia-Lymphoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prospective Studies", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "name": [
                "Service d'H\u00e9matologie et Oncologie M\u00e9dicale, CHU, Poitiers, France."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Millot", 
            "givenName": "F", 
            "id": "sg:person.01276534111.72", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276534111.72"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Dhondt", 
            "givenName": "J L", 
            "id": "sg:person.0100226714.64", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0100226714.64"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Mazingue", 
            "givenName": "F", 
            "id": "sg:person.015532007144.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015532007144.00"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Mechinaud", 
            "givenName": "F", 
            "id": "sg:person.01010501035.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010501035.86"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Ingrand", 
            "givenName": "P", 
            "id": "sg:person.01066211233.51", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066211233.51"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Guilhot", 
            "givenName": "F", 
            "id": "sg:person.0766311767.93", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766311767.93"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1016/s0022-3476(89)80312-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010892741"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01800658", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016960884", 
              "https://doi.org/10.1007/bf01800658"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1007/bf01800658", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016960884"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/1097-0142(19870701)60:1<5::aid-cncr2820600103>3.0.co;2-d", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020563723"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/1097-0142(19850915)56:6<1356::aid-cncr2820560623>3.0.co;2-h", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037465655"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejm197507242930402", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037469348"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/00043426-199208000-00018", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046153556"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/00043426-199208000-00018", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046153556"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0959-8049(92)90045-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047260522"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0022-3476(86)80904-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049002385"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1432-1033.1991.tb21072.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049255704"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1995-02", 
        "datePublishedReg": "1995-02-01", 
        "description": "Acute or subacute neurologic disorders can be observed in patients receiving high-dose methotrexate therapy for lymphoblastic leukemia or malignant tumor. Impairment of biopterin metabolism leading to decreased availability of monoamine neurotransmitters has been suggested to explain methotrexate neurotoxicity. To investigate such a mechanism, we have measured prospectively by HPLC the concentrations of total biopterin, homovanillic acid, and 5-hydroxyindolacetic acid in cerebrospinal fluid of 57 children with acute lymphoblastic leukemia. A sequential analysis of cerebrospinal fluid was performed for each patient: cerebrospinal fluid samples were obtained before therapy and after each of the four high-dose methotrexate infusions during the CNS prophylaxis phase. A significant increase of total biopterin concentrations in cerebrospinal fluid was observed after high-dose methotrexate therapy compared with the pretreatment values. No cumulative effect was noted. In contrast, no significant variation of the homovanillic acid and 5-hydroxyindolacetic acid levels was observed in cerebrospinal fluid. However, individual analysis revealed a transient decrease of homovanillic acid and 5-hydroxyindolacetic acid concentrations in cerebrospinal fluid of six children. The increase of total biopterin mimicking that observed in inherited dihydropteridine reductase deficiencies suggests that methotrexate inhibits the regenerating system of biopterin in the brain of patients undergoing high-dose methotrexate therapy.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1203/00006450-199502000-00004", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1007352", 
            "issn": [
              "0031-3998", 
              "1530-0447"
            ], 
            "name": "Pediatric Research", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "37"
          }
        ], 
        "name": "Changes of Cerebral Biopterin and Biogenic Amine Metabolism in Leukemic Children Receiving 5 g/m2 Intravenous Methotrexate", 
        "pagination": "151", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "0805aae99c3db32e75b9c0bf4929f451dce2af6b88b63f2a798210b1ca8d7f7c"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "7537364"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0100714"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1203/00006450-199502000-00004"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1001684512"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1203/00006450-199502000-00004", 
          "https://app.dimensions.ai/details/publication/pub.1001684512"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-10T19:44", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000421.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://www.nature.com/articles/pr199527"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1203/00006450-199502000-00004'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1203/00006450-199502000-00004'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1203/00006450-199502000-00004'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1203/00006450-199502000-00004'


     

    This table displays all metadata directly associated to this object as RDF triples.

    217 TRIPLES      21 PREDICATES      61 URIs      43 LITERALS      31 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1203/00006450-199502000-00004 schema:about N02ed14c3af18426d8f0971875c11372b
    2 N1cd9a68e56ea40d0b21fc5503ceed8fd
    3 N35764a47b9594d66810f3abe36a1cb69
    4 N3bf5cfdabf504ac79e6e1868502eaae2
    5 N7912a7841ff94d2f83552af29bb51b53
    6 N7bb8cfcf394d40509c12542bc05e1307
    7 N809c78a67c994f78825110418072ba8b
    8 N829891d1d5a943a3aeca30d32f6a470c
    9 N848caf82454f475b8034b5872e65b708
    10 N8a507c8abba542789fd6c030650e1121
    11 N8cc3c5d4e6f3454b9f9a6766208bf3e0
    12 Na2e6676a97ea4144ad0193bc2a4db672
    13 Na7ce3668e59b46de9447e410887e36e6
    14 Nb1814092529d4760aaaf30ef6a5d6fc2
    15 Ncbeee6e15c0f49c1a655b8efa7165629
    16 Ncde27bb32b2942e4b3f39baf86adc52c
    17 Nd02cf455b1d74ce2a48f12e0f0ccdd7a
    18 Nd8b216d95822456088344fa422938d79
    19 Neaeabe0835104c6bbab786f8541cb015
    20 Nf583394174554018a76b3065219e363f
    21 Nf62c88b1df66474895026c68d51335f1
    22 Nf81b572e7a6141f385d6ffa2a64f9924
    23 anzsrc-for:11
    24 anzsrc-for:1103
    25 schema:author N73ef67f5b6634b4ba4bce16cd6e4fbf3
    26 schema:citation sg:pub.10.1007/bf01800658
    27 https://doi.org/10.1002/1097-0142(19850915)56:6<1356::aid-cncr2820560623>3.0.co;2-h
    28 https://doi.org/10.1002/1097-0142(19870701)60:1<5::aid-cncr2820600103>3.0.co;2-d
    29 https://doi.org/10.1007/bf01800658
    30 https://doi.org/10.1016/0959-8049(92)90045-4
    31 https://doi.org/10.1016/s0022-3476(86)80904-0
    32 https://doi.org/10.1016/s0022-3476(89)80312-9
    33 https://doi.org/10.1056/nejm197507242930402
    34 https://doi.org/10.1097/00043426-199208000-00018
    35 https://doi.org/10.1111/j.1432-1033.1991.tb21072.x
    36 schema:datePublished 1995-02
    37 schema:datePublishedReg 1995-02-01
    38 schema:description Acute or subacute neurologic disorders can be observed in patients receiving high-dose methotrexate therapy for lymphoblastic leukemia or malignant tumor. Impairment of biopterin metabolism leading to decreased availability of monoamine neurotransmitters has been suggested to explain methotrexate neurotoxicity. To investigate such a mechanism, we have measured prospectively by HPLC the concentrations of total biopterin, homovanillic acid, and 5-hydroxyindolacetic acid in cerebrospinal fluid of 57 children with acute lymphoblastic leukemia. A sequential analysis of cerebrospinal fluid was performed for each patient: cerebrospinal fluid samples were obtained before therapy and after each of the four high-dose methotrexate infusions during the CNS prophylaxis phase. A significant increase of total biopterin concentrations in cerebrospinal fluid was observed after high-dose methotrexate therapy compared with the pretreatment values. No cumulative effect was noted. In contrast, no significant variation of the homovanillic acid and 5-hydroxyindolacetic acid levels was observed in cerebrospinal fluid. However, individual analysis revealed a transient decrease of homovanillic acid and 5-hydroxyindolacetic acid concentrations in cerebrospinal fluid of six children. The increase of total biopterin mimicking that observed in inherited dihydropteridine reductase deficiencies suggests that methotrexate inhibits the regenerating system of biopterin in the brain of patients undergoing high-dose methotrexate therapy.
    39 schema:genre research_article
    40 schema:inLanguage en
    41 schema:isAccessibleForFree true
    42 schema:isPartOf N556c63886a274c3789fca1e3c8f5dfbe
    43 N8d6387422cd5438db756c2c0bdafdb88
    44 sg:journal.1007352
    45 schema:name Changes of Cerebral Biopterin and Biogenic Amine Metabolism in Leukemic Children Receiving 5 g/m2 Intravenous Methotrexate
    46 schema:pagination 151
    47 schema:productId N4778330b6d344e17ada8d7aab924a035
    48 N5ebb6765448c42b483d5bec45f94b5ef
    49 Nc774c7d800a94f1488df23a0fb6c1b64
    50 Nd25eb341f3394ed48600897e86816cff
    51 Nf4e55681e0954ceb98d33c5720736177
    52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001684512
    53 https://doi.org/10.1203/00006450-199502000-00004
    54 schema:sdDatePublished 2019-04-10T19:44
    55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    56 schema:sdPublisher N94bbe474ae294ab99f1c0cf09ae1cf9c
    57 schema:url https://www.nature.com/articles/pr199527
    58 sgo:license sg:explorer/license/
    59 sgo:sdDataset articles
    60 rdf:type schema:ScholarlyArticle
    61 N02ed14c3af18426d8f0971875c11372b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    62 schema:name Male
    63 rdf:type schema:DefinedTerm
    64 N08b7b70ae2c6409986f5fd88d9da6879 rdf:first sg:person.01066211233.51
    65 rdf:rest N6c71144ae2624c92bf7368fb13ec9fdf
    66 N1cd9a68e56ea40d0b21fc5503ceed8fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    67 schema:name Child, Preschool
    68 rdf:type schema:DefinedTerm
    69 N35764a47b9594d66810f3abe36a1cb69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    70 schema:name Precursor Cell Lymphoblastic Leukemia-Lymphoma
    71 rdf:type schema:DefinedTerm
    72 N3bf5cfdabf504ac79e6e1868502eaae2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    73 schema:name Prospective Studies
    74 rdf:type schema:DefinedTerm
    75 N3bf8d945933c4b218f30795c80332919 schema:name Service d'Hématologie et Oncologie Médicale, CHU, Poitiers, France.
    76 rdf:type schema:Organization
    77 N4778330b6d344e17ada8d7aab924a035 schema:name doi
    78 schema:value 10.1203/00006450-199502000-00004
    79 rdf:type schema:PropertyValue
    80 N55480c70a4af4131881e59ec7a7ab30e rdf:first sg:person.015532007144.00
    81 rdf:rest N66f60bc3be194fe38c378ab35a70bdbe
    82 N556c63886a274c3789fca1e3c8f5dfbe schema:issueNumber 2
    83 rdf:type schema:PublicationIssue
    84 N5ebb6765448c42b483d5bec45f94b5ef schema:name readcube_id
    85 schema:value 0805aae99c3db32e75b9c0bf4929f451dce2af6b88b63f2a798210b1ca8d7f7c
    86 rdf:type schema:PropertyValue
    87 N66f60bc3be194fe38c378ab35a70bdbe rdf:first sg:person.01010501035.86
    88 rdf:rest N08b7b70ae2c6409986f5fd88d9da6879
    89 N6c71144ae2624c92bf7368fb13ec9fdf rdf:first sg:person.0766311767.93
    90 rdf:rest rdf:nil
    91 N73ef67f5b6634b4ba4bce16cd6e4fbf3 rdf:first sg:person.01276534111.72
    92 rdf:rest Nd906bbaf29b54a79a14f8154352a9ff5
    93 N7912a7841ff94d2f83552af29bb51b53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    94 schema:name Biopterin
    95 rdf:type schema:DefinedTerm
    96 N7bb8cfcf394d40509c12542bc05e1307 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    97 schema:name Infusions, Intravenous
    98 rdf:type schema:DefinedTerm
    99 N809c78a67c994f78825110418072ba8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    100 schema:name Antineoplastic Combined Chemotherapy Protocols
    101 rdf:type schema:DefinedTerm
    102 N829891d1d5a943a3aeca30d32f6a470c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    103 schema:name Female
    104 rdf:type schema:DefinedTerm
    105 N848caf82454f475b8034b5872e65b708 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    106 schema:name Nerve Tissue Proteins
    107 rdf:type schema:DefinedTerm
    108 N8a507c8abba542789fd6c030650e1121 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Cytarabine
    110 rdf:type schema:DefinedTerm
    111 N8cc3c5d4e6f3454b9f9a6766208bf3e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Methotrexate
    113 rdf:type schema:DefinedTerm
    114 N8d6387422cd5438db756c2c0bdafdb88 schema:volumeNumber 37
    115 rdf:type schema:PublicationVolume
    116 N94bbe474ae294ab99f1c0cf09ae1cf9c schema:name Springer Nature - SN SciGraph project
    117 rdf:type schema:Organization
    118 Na2e6676a97ea4144ad0193bc2a4db672 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Dihydropteridine Reductase
    120 rdf:type schema:DefinedTerm
    121 Na7ce3668e59b46de9447e410887e36e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Adolescent
    123 rdf:type schema:DefinedTerm
    124 Nb1814092529d4760aaaf30ef6a5d6fc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Homovanillic Acid
    126 rdf:type schema:DefinedTerm
    127 Nc774c7d800a94f1488df23a0fb6c1b64 schema:name pubmed_id
    128 schema:value 7537364
    129 rdf:type schema:PropertyValue
    130 Ncbeee6e15c0f49c1a655b8efa7165629 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Infant
    132 rdf:type schema:DefinedTerm
    133 Ncde27bb32b2942e4b3f39baf86adc52c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Humans
    135 rdf:type schema:DefinedTerm
    136 Nd02cf455b1d74ce2a48f12e0f0ccdd7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Child
    138 rdf:type schema:DefinedTerm
    139 Nd25eb341f3394ed48600897e86816cff schema:name dimensions_id
    140 schema:value pub.1001684512
    141 rdf:type schema:PropertyValue
    142 Nd8b216d95822456088344fa422938d79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name Biogenic Amines
    144 rdf:type schema:DefinedTerm
    145 Nd906bbaf29b54a79a14f8154352a9ff5 rdf:first sg:person.0100226714.64
    146 rdf:rest N55480c70a4af4131881e59ec7a7ab30e
    147 Neaeabe0835104c6bbab786f8541cb015 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Chromatography, High Pressure Liquid
    149 rdf:type schema:DefinedTerm
    150 Nf4e55681e0954ceb98d33c5720736177 schema:name nlm_unique_id
    151 schema:value 0100714
    152 rdf:type schema:PropertyValue
    153 Nf583394174554018a76b3065219e363f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Hydroxyindoleacetic Acid
    155 rdf:type schema:DefinedTerm
    156 Nf62c88b1df66474895026c68d51335f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Brain Chemistry
    158 rdf:type schema:DefinedTerm
    159 Nf81b572e7a6141f385d6ffa2a64f9924 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Mercaptopurine
    161 rdf:type schema:DefinedTerm
    162 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    163 schema:name Medical and Health Sciences
    164 rdf:type schema:DefinedTerm
    165 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    166 schema:name Clinical Sciences
    167 rdf:type schema:DefinedTerm
    168 sg:journal.1007352 schema:issn 0031-3998
    169 1530-0447
    170 schema:name Pediatric Research
    171 rdf:type schema:Periodical
    172 sg:person.0100226714.64 schema:familyName Dhondt
    173 schema:givenName J L
    174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0100226714.64
    175 rdf:type schema:Person
    176 sg:person.01010501035.86 schema:familyName Mechinaud
    177 schema:givenName F
    178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010501035.86
    179 rdf:type schema:Person
    180 sg:person.01066211233.51 schema:familyName Ingrand
    181 schema:givenName P
    182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066211233.51
    183 rdf:type schema:Person
    184 sg:person.01276534111.72 schema:affiliation N3bf8d945933c4b218f30795c80332919
    185 schema:familyName Millot
    186 schema:givenName F
    187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276534111.72
    188 rdf:type schema:Person
    189 sg:person.015532007144.00 schema:familyName Mazingue
    190 schema:givenName F
    191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015532007144.00
    192 rdf:type schema:Person
    193 sg:person.0766311767.93 schema:familyName Guilhot
    194 schema:givenName F
    195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766311767.93
    196 rdf:type schema:Person
    197 sg:pub.10.1007/bf01800658 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016960884
    198 https://doi.org/10.1007/bf01800658
    199 rdf:type schema:CreativeWork
    200 https://doi.org/10.1002/1097-0142(19850915)56:6<1356::aid-cncr2820560623>3.0.co;2-h schema:sameAs https://app.dimensions.ai/details/publication/pub.1037465655
    201 rdf:type schema:CreativeWork
    202 https://doi.org/10.1002/1097-0142(19870701)60:1<5::aid-cncr2820600103>3.0.co;2-d schema:sameAs https://app.dimensions.ai/details/publication/pub.1020563723
    203 rdf:type schema:CreativeWork
    204 https://doi.org/10.1007/bf01800658 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016960884
    205 rdf:type schema:CreativeWork
    206 https://doi.org/10.1016/0959-8049(92)90045-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047260522
    207 rdf:type schema:CreativeWork
    208 https://doi.org/10.1016/s0022-3476(86)80904-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049002385
    209 rdf:type schema:CreativeWork
    210 https://doi.org/10.1016/s0022-3476(89)80312-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010892741
    211 rdf:type schema:CreativeWork
    212 https://doi.org/10.1056/nejm197507242930402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037469348
    213 rdf:type schema:CreativeWork
    214 https://doi.org/10.1097/00043426-199208000-00018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046153556
    215 rdf:type schema:CreativeWork
    216 https://doi.org/10.1111/j.1432-1033.1991.tb21072.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049255704
    217 rdf:type schema:CreativeWork
     




    Preview window. Press ESC to close (or click here)


    ...